PTGX · Protagonist Therapeutics, Inc · Investor Relations
$140.06
+0.87 (+0.63%)
At close · Oct 2
Return incl. dividend (before tax)
Market Cap
$9.18B
Shares
64.71M
Volume · Oct 2
760.3K
Avg daily vol (3M)
634.39K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-09-25 | WSJ: The Peptide Boom That Isn’t About Your Muscles | Event |
| 2026-09-10 | Protagonist at the Cantor Global Healthcare Conference | Conference |
| 2026-09-09 | Protagonist at the Citi Biopharma Back to School Summit | Event |
| 2026-09-08 | Corporate Presentation | Presentation |
| 2026-08-31 | US FDA Approval of MIMRYLO™(rusfertide) for Treatment of Erythrocytosis in Adults with Polycythemia Vera (PV) | Event |
| 2026-08-28 | U.S. FDA Approves MIMRYLO™ (rusfertide) | Event |
| 2026-08-05 | Corporate Presentation | Presentation |
| 2026-06-03 | Protagonist at the Jefferies Global Healthcare Conference | Conference |
| 2026-06-02 | Corporate Presentation | Presentation |
| 2026-03-12 | Barclays Global Healthcare Conference | Conference |
| 2026-01-16 | Protagonist Speaks to BioSpace at #JPM26 | Event |
Source: https://www.protagonist-inc.com/investor-email-alerts